Inhibition of Kdm6a restores the H3k27me3 modification, reduces the Cry1 expression in the hypothalamus, and sensitizes leptin signaling to combat obesity‐related disease. Here, CRY1 is linked to obesity due to melanocortin 4 receptor deficiency.